Skip to content

Loyal

StartupUS1 field

Website

Where it works

Technology
Longevity biotechVeterinary drug company developing FDA-approved lifespan extension drugs for dogs.

Events

DateEvent
Sep 16, 2026Loyal's large-dog lifespan drug LOY-003 earns FDA RXEloyal.com· Milestone· Longevity biotech
Jan 13, 2026FDA accepts safety section for Loyal's LOY-002loyal.com· Milestone· Longevity biotech
Jul 14, 2025Loyal completes enrollment of the STAY study at 1,300 dogsloyal.com· Milestone· Longevity biotech
Apr 14, 2025Loyal's STAY study enrolls 1,000 dogsloyal.com· Milestone· Longevity biotech
Feb 26, 2025FDA accepts efficacy case for Loyal's senior dog lifespan drugloyal.com· Milestone· Longevity biotech
Feb 1, 2024Loyal doses the first dog in its LOY-002 pivotal lifespan studyloyal.com· Milestone· Longevity biotech

Funding

DateRoundAmount
Feb 11, 2026Series CLed by age1, The Longevity Fund$100M
Mar 21, 2024Series BLed by Bain Capital Ventures$45M
About
Source
loyal.com (official, added by seed)
First seen
Sep 25, 2026
Last seen
Sep 25, 2026
DateChange
Sep 25, 2026LoyalCompany in Longevity biotech: Joined a field, Veterinary drug company developing FDA-approved lifespan extension drugs for dogs.
Sep 25, 2026LoyalCompany: Added

Frontier tech by email

Tuesdays, only in weeks with new milestones, rounds or stage changes in the fields tracked here.

Double opt-in. Unsubscribe any time.